Evidence map›Paper›PMID 37903249›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Omicron breakthrough infections in vaccinated or previously infected hamsters.

Jie Zhou, Ksenia Sukhova, Thomas P Peacock, Paul F McKay, Jonathan C Brown, Rebecca Frise, Laury Baillon, Maya Moshe, Ruthiran Kugathasan, Robin J Shattock and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jie Zhou *Department of Infectious Disease, Imperial College London, London W2 1PG, United Kingdom.ORCID 0000-0002-6413-2454
Ksenia Sukhova *Department of Infectious Disease, Imperial College London, London W2 1PG, United Kingdom.
Thomas P Peacock *Department of Infectious Disease, Imperial College London, London W2 1PG, United Kingdom.ORCID 0000-0001-7077-2928
Paul F McKayDepartment of Infectious Disease, Imperial College London, London W2 1PG, United Kingdom.ORCID 0000-0001-5195-6254
Jonathan C BrownDepartment of Infectious Disease, Imperial College London, London W2 1PG, United Kingdom.
Rebecca FriseDepartment of Infectious Disease, Imperial College London, London W2 1PG, United Kingdom.
Laury BaillonDepartment of Infectious Disease, Imperial College London, London W2 1PG, United Kingdom.
Maya MosheDepartment of Infectious Disease, Imperial College London, London W2 1PG, United Kingdom.
Ruthiran KugathasanDepartment of Infectious Disease, Imperial College London, London W2 1PG, United Kingdom.
Robin J ShattockDepartment of Infectious Disease, Imperial College London, London W2 1PG, United Kingdom.
Wendy S BarclayDepartment of Infectious Disease, Imperial College London, London W2 1PG, United Kingdom.ORCID 0000-0002-3948-0895
Imperial College London · GB

Funding

Medical Research Council MR/W005611/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/K00042X/1Wellcome Trust
6 · The paper itself

Abstract

The ongoing SARS-CoV-2 epidemic was marked by the repeated emergence and replacement of "variants" with genetic and phenotypic distance from the ancestral strains, the most recent examples being viruses of the Omicron lineage. Here, we describe a hamster direct contact exposure challenge model to assess protection against reinfection conferred by either vaccination or prior infection. We found that two doses of self-amplifying RNA vaccine based on the ancestral Spike ameliorated weight loss following Delta infection and decreased viral loads but had minimal effect on Omicron BA.1 infection. Prior vaccination followed by Delta or BA.1 breakthrough infections led to a high degree of cross-reactivity to all tested variants, suggesting that repeated exposure to antigenically distinct Spikes, via infection and/or vaccination drives a cross-reactive immune response. Prior infection with ancestral or Alpha variant was partially protective against BA.1 infection, whereas all animals previously infected with Delta and exposed to BA.1 became reinfected, although they shed less virus than BA.1-infected naive hamsters. Hamsters reinfected with BA.1 after prior Delta infection emitted infectious virus into the air, indicating that they could be responsible for onwards airborne transmission. We further tested whether prior infection with BA.1 protected from reinfection with Delta or later Omicron sublineages BA.2, BA.4, or BA.5. BA.1 was protective against BA.2 but not against Delta, BA.4, or BA.5 reinfection. These findings suggest that cohorts whose only immune experience of COVID-19 is Omicron BA.1 infection may be vulnerable to future circulation of reemerged Delta-like derivatives, as well as emerging Omicron sublineages.

Indexed as

COVID-19Hepatitis DAnimalsAntibodies, NeutralizingAntibodies, ViralBreakthrough InfectionsCricetinaeCross ReactionsReinfectionAntibodies, NeutralizingAntibodies, ViralhamsterreinfectionSARS-CoV-2transmissionvaccine

Identifiers

PMID37903249
PMCPMC10636328
OpenAlexW4388035275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.